Superluminal Medicines

Funding and NIH signals

• SEC Form D raise Raised $65.48M (Form D filed Sep 3, 2026). SEC Form D 0001989478-26-000001 (Sep 3, 2026)
  Evidence (1 event)

  • Sep 3, 2026 · SEC Form D 0001989478-26-000001
    Name of Issuer: Superluminal Medicines, Inc.; CIK: 1989478; Address: Boston, MA; Submission type: D; Filing date: 2026-09-03; Industry Group: Biotechnology; Date of First Sale: 2026-08-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 65480796; Total Amount Sold: 65480796; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals